Episode 324: Dr. Ashlyn Sanders
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
Dr. Sanders shares her personal journey following her diagnosis with Chiari Malformation, which required emergency brain surgery and led to her experiencing seizures herself. That experience fueled her mission to improve seizure care and address a long-standing gap in patient safety.
The conversation focuses on the development of the PATI (Patient Airway and Tongue Injury Prevention) device, the first FDA-cleared seizure oral protection device designed to reduce oral injuries that occur in nearly one in five seizure patients. Steve and Dr. Sanders discuss challenging traditional teaching, advancing evidence-based care, and how innovation can improve outcomes for patients and providers alike. This episode highlights the intersection of personal experience, clinical insight, and innovation aimed at changing the standard of care in seizure management.
Subscribe to Medic2Medic wherever you get your podcasts and share this episode with someone interested in advancing patient-centered innovation in EMS and healthcare.
https://www.spreaker.com/episode/episode-324-dr-ashlyn-sanders--71085446
Todavía no hay opiniones